Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Law

Showing results (161-170 of 204) with videos related to

Pageof 21
Sort By:
Iscience|February 2, 2026
Patient-derived organoid xenografts model esophageal cancer cachexia and enable assessment of anti-inflammatory drug repositioningBryan Chee-Chad Lung, Alvin Ka-Kiu Leung, Carissa Wing-Yan Wong, et al.
International Journal of Cancer|October 19, 2007
Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinomaAlfred Chi Chung Leung, Victor Chun Lam Wong, Li Chun Yang, et al.
The British Journal of Surgery|August 29, 2022
Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparisonBen M Eyck, Xing Gao, Yang Yang, et al.
Cancers|May 30, 2020
Liquid Biopsy Serial Monitoring of Treatment Responses and Relapse in Advanced Esophageal Squamous Cell CarcinomaJosephine Mun Yee Ko, Hoi Yan Ng, Ka On Lam, et al.
International Journal of Cancer|March 10, 2011
Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotypeVictor Chun Lam Wong, Han Chen, Josephine Mun Yee Ko, et al.
Annals of Surgical Oncology|October 28, 2022
Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell CarcinomaWing-Lok Chan, Cheuk-Wai Choi, Ian Yu-Hong Wong, et al.
Cancer Research|June 17, 2010
Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesisPaulisally Hau Yi Lo, Hong Lok Lung, Arthur Kwok Leung Cheung, et al.
Annals of Surgery|December 25, 2009
Optimum lymphadenectomy for esophageal cancerNabil P Rizk, Hemant Ishwaran, Thomas W Rice, et al.
Annals of the New York Academy of Sciences|October 15, 2013
Barrett's esophagus: cancer and molecular biologyMichael K Gibson, Arashinder S Dhaliwal, Nicholas J Clemons, et al.
International Journal of Cancer|August 10, 2019
BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in ChineseJosephine Mun-Yee Ko, Lvwen Ning, Xue-Ke Zhao, et al.
Pageof 21

Showing results (161-170 of 204) with videos related to

Sort By:
Pageof 21
Iscience|February 2, 2026
Patient-derived organoid xenografts model esophageal cancer cachexia and enable assessment of anti-inflammatory drug repositioningBryan Chee-Chad Lung, Alvin Ka-Kiu Leung, Carissa Wing-Yan Wong, et al.
International Journal of Cancer|October 19, 2007
Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage-independent growth properties and impact on global gene expression in esophageal carcinomaAlfred Chi Chung Leung, Victor Chun Lam Wong, Li Chun Yang, et al.
The British Journal of Surgery|August 29, 2022
Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparisonBen M Eyck, Xing Gao, Yang Yang, et al.
Cancers|May 30, 2020
Liquid Biopsy Serial Monitoring of Treatment Responses and Relapse in Advanced Esophageal Squamous Cell CarcinomaJosephine Mun Yee Ko, Hoi Yan Ng, Ka On Lam, et al.
International Journal of Cancer|March 10, 2011
Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotypeVictor Chun Lam Wong, Han Chen, Josephine Mun Yee Ko, et al.
Annals of Surgical Oncology|October 28, 2022
Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell CarcinomaWing-Lok Chan, Cheuk-Wai Choi, Ian Yu-Hong Wong, et al.
Cancer Research|June 17, 2010
Extracellular protease ADAMTS9 suppresses esophageal and nasopharyngeal carcinoma tumor formation by inhibiting angiogenesisPaulisally Hau Yi Lo, Hong Lok Lung, Arthur Kwok Leung Cheung, et al.
Annals of Surgery|December 25, 2009
Optimum lymphadenectomy for esophageal cancerNabil P Rizk, Hemant Ishwaran, Thomas W Rice, et al.
Annals of the New York Academy of Sciences|October 15, 2013
Barrett's esophagus: cancer and molecular biologyMichael K Gibson, Arashinder S Dhaliwal, Nicholas J Clemons, et al.
International Journal of Cancer|August 10, 2019
BRCA2 loss-of-function germline mutations are associated with esophageal squamous cell carcinoma risk in ChineseJosephine Mun-Yee Ko, Lvwen Ning, Xue-Ke Zhao, et al.
Pageof 21